Government’s Initiative to Reduce Import Dependence on China and Boost Domestic API Manufacturing The Government of India is taking decisive steps to enhance domestic manufacturing of Active Pharmaceutical Ingredients (APIs), Key Starting Materials (KSMs), and Drug Intermediates (DIs) through the Production Linked Incentive (PLI) Scheme. This
